| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 3,907,000 | 4,910,000 | 4,853,000 | 4,487,000 | | Cost of Revenue | 3,239,000 | 3,686,000 | 3,725,000 | 3,492,000 | | | Gross Profit | 668,000 | 1,224,000 | 1,128,000 | 995,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 52,000 | 61,000 | 78,000 | 71,000 | | Non Recurring |
-
|
-
| (1,000) | (25,000) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 616,000 | 1,163,000 | 1,051,000 | 949,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (3,000) | (22,000) | (691,000) | 7,000 | | Earnings Before Interest And Taxes | 613,000 | 1,141,000 | 360,000 | 956,000 | | Interest Expense | 53,000 | 48,000 | 35,000 | 39,000 | | Income Before Tax | 560,000 | 1,093,000 | 325,000 | 917,000 | | Income Tax Expense | 179,000 | 342,000 | 343,000 | 288,000 | | Minority Interest | (2,000) | 25,000 | (3,000) | (6,000) | | | | Net Income From Continuing Ops | 379,000 | 776,000 | (21,000) | 623,000 | | | Non-recurring Events | | Discontinued Operations | (1,000) | (308,000) |
-
| (116,000) | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 378,000 | 468,000 | (21,000) | 507,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $378,000 | $468,000 | ($21,000) | $507,000 |
|
0.45% Nasdaq 
0.20%
Income Statement
